Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Pronorvistaon Nov 02, 2023 4:05pm
199 Views
Post# 35714427

ATE

ATELittle volume on the side US .


Q:ATBPF - ANTIBE THERAPEUTICS INC - Website unknown - click to update
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
ATBPF - Q not subscribed 0.5578 +0.0228 4.3 51.6 27 40 0.5764  0.5764  0.5578 0.53  0.281 11:51:13 Nov 01 15 min RT 2¢

 

Recent Trades - Last 10 of 40
Time ET Ex Price Change Volume
11:51:13 Q 0.5614 0.0264 50
11:32:37 Q 0.5578 0.0228 1,000
11:32:33 Q 0.5578 0.0228 1,000
11:32:30 Q 0.5578 0.0228 1,000
11:32:26 Q 0.5578 0.0228 1,000
11:32:23 Q 0.5578 0.0228 1,000
11:32:18 Q 0.5578 0.0228 1,000
11:32:15 Q 0.5578 0.0228 1,000
11:32:11 Q 0.5578 0.0228 1,000
11:32:08 Q 0.5578 0.0228 1,000

<< Previous
Bullboard Posts
Next >>